CVS Health raises benefits operating profit outlook

CVS Health raised its full-year outlook for its Health Care Benefits segment following stronger underlying trends across the first half of the year. The company now projects adjusted operating income between $5.03 billion and $5.37 billion for the division, which is more than $1 billion higher than its prior guidance. Full-year medical benefit ratio (MBR), which tracks medical costs as a share of premiums, is projected at 89.8%, plus or minus 25 basis points, reflecting what management termed a prudent view of second-half medical cost trends.

During the second quarter of 2026, strength in the Government business lifted Health Care Benefits revenues by more than 3% year over year to exceed $37 billion. Second-quarter adjusted operating income reached approximately $2.4 billion, and the quarterly MBR stood at 87.4%. Those figures included changes in the individual exchange risk adjustment position for the 2025 plan year and favorable prior-year development, which together provided roughly $500 million, or 140 basis points, to the quarter's MBR. Core performance also exceeded expectations when excluding those items, led by Medicare, disciplined pricing, and cost management, while Medicaid and Commercial performance met internal expectations.

At the close of the second quarter, medical membership was approximately 26 million. That total was unchanged from the previous quarter but down by about 700,000 members from the prior-year period, largely reflecting CVS Health's exit from the Individual exchange business, which was partially offset by growth in commercial fee-based membership.

In parallel commercial developments, Cardinal Health signed a binding Letter of Intent to extend its distribution partnership with CVS Health through June 30, 2032. Separately, over the past six months, CVS Health shares rose 11.3%, compared with a 12.4% gain for the broader industry. The stock trades at a forward 12-month price-to-earnings ratio of 10.36, below the industry average of 16.09, while consensus earnings estimates for 2026 and 2027 rose 7.5% and 1.4%, respectively, over the past 60 days.